On September 27, Wang Hongchen, Wang Jinghua and Sun Jia, experts from Zhongzhi (Beijing) Certification Co., Ltd., formed an audit team to conduct an on-site audit of Chuancheng Pharmaceutical's intellectual property management system certification. Han Hongfen, the administrative director of Chuancheng Pharmaceutical, and heads of relevant departments participated in the on-site audit.
In the process of on-site inspection, the audit team reviews the company's R&D, production, business, human resources, finance, material control, comprehensive and other departments by means of dialogue and communication, inspection records and on-site confirmation, and evaluates the planning, implementation, improvement and other aspects of the entire intellectual property management system. The audit team affirmed the work done by Chuancheng Pharmaceutical in the aspect of intellectual property certification, and believed that Chuancheng Pharmaceutical's intellectual property management system conforms to the enterprise's intellectual property management specifications, and effectively controls the intellectual property activities in research and development, procurement, production, sales and other links during the operation process. At the same time, the audit team put forward suggestions and opinions on intellectual property layout, contract management, intellectual property risk management and control, etc. At the closing meeting, the audit team made a final evaluation based on the on-site audit, and Chuancheng Pharmaceutical successfully obtained the qualification of intellectual property management system certification.
The passing of the on-site audit of the intellectual property management system certification marks that the intellectual property management level of Chuancheng Pharmaceutical has reached a new level. Chuancheng Pharmaceutical will take this opportunity to continuously strengthen the creation, application, protection and standardized management of intellectual property rights, better prevent intellectual property risks in production and operation, solidly promote technological innovation and management innovation, and make new efforts to strengthen the core competitiveness of intellectual property rights and promote the long-term, sustainable and healthy development of the company.